Carregant...
Comparison of botulinum neurotoxin type A formulations in Asia
RESULTS: All protein-based therapeutics, such as botulinum neurotoxin type A (BoNT/A), are potentially immunogenic and can lead to anaphylaxis, autoimmunity, or diminished or complete absence of therapeutic efficacy, especially if administered repeatedly. Therefore, the protein quantity in BoNT/A pr...
Guardat en:
| Publicat a: | Clin Cosmet Investig Dermatol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6039073/ https://ncbi.nlm.nih.gov/pubmed/30013379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S160723 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|